June 14, 2017- Concept to Commercialization : Why the Current CRO Model May Be Failing Developers, Investors and Patients

Date
8am - 10am
Location
Biocom-10996 Torreyana Road, Suite 200, San Diego, CA 92121
Speakers:
James Nolan , CEO, InClinica , ,

“Concept to Commercialization : Why the Current CRO Model May Be Failing Developers, Investors and Patients”

The first in a series of “Concept to Commercialization” presentations, this lecture will examine why the current CRO model may be failing developers, investors and patients. Does a new model CRO need introduction to the industry? Yes, according to pharmaceutical leader James Nolan, one that includes these four, key elements and available at the earliest stages of development:

• A reimbursement strategy
• Regulatory experts
• Pre-IND evaluation capabilities
• Patient access experts.

These added capabilities will allow CROs to separate themselves in a highly competitive industry. Mr. Nolan will also detail key issues complicating the concept to commercialization path for drug developers.